Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Illumina Inc (NASDAQ: ILMN) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Illumina Inc (NASDAQ: ILMN) concerning whether a series of statements by Illumina Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On October 10, 2016, the Company revealed estimated third quarter fiscal year 2016 revenue of approximately $607 million, which was lower than its guidance of $625 million to $630 million. Illumina attributed the shortfall to a “larger than anticipated year-over-year decline in high throughput sequencing instruments.”

Following this news, NASDAQ: ILMN fell $45.86 per share or over 24% from its previous closing price to close at $138.99 per share on October 11, 2016.

On December 16, 2016, the Company was sued for alleged violations of the federal securities laws.

Based in San Diego, California, and founded in 1998 Illumina Inc provides sequencing and array-based solutions for genetic analysis.

If you purchased shares of Illumina Inc (NASDAQ: ILMN) on or before October 10, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185